Prophylactic Mastectomy

Shaheen Zakaria, Amy C. Degnim

Research output: Contribution to journalReview article

15 Scopus citations

Abstract

With availability of genetic testing and development of statistical models for risk stratification, more women are being identified as having increased risk for breast cancer. A number of risk-reducing treatment options with varying efficacy exist for them, including frequent surveillance, chemoprevention, prophylactic salpingo-oophorectomy (PSO), and prophylactic mastectomy (PM). Those most likely to benefit from PM are BRCA gene carriers and those who have a strong family history of breast cancer. Prevetive PM remains controversial, however. There are no randomized controlled trials to substantiate the potential benefit or harms of PM. This article describes the high-risk women in whom PM may be considered, and summarizes data on the efficacy of PM as a treatment for the prevention of breast cancer.

Original languageEnglish (US)
Pages (from-to)317-331
Number of pages15
JournalSurgical Clinics of North America
Volume87
Issue number2
DOIs
StatePublished - Apr 1 2007

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Prophylactic Mastectomy'. Together they form a unique fingerprint.

  • Cite this